ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Utilization and Discard of Organs from Covid -19 Infected Donors: A Us National Registry Analysis

A. Azhar1, I. Moinuddin1, A. B. Gungor2, M. K. Morales1, M. Z. Molnar3, B. Tanriover2, G. Gupta1

1Virginia Commonwealth University, Richmond, VA, 2University of Arizona, Tuscon, AZ, 3University of Utah, Salt Lake City, UT

Meeting: 2022 American Transplant Congress

Abstract number: 158

Keywords: COVID-19, Donation

Topic: Clinical Science » Infection Disease » 24 - All Infections (Excluding Kidney & Viral Hepatitis)

Session Information

Session Name: COVID-19 Infections Part 1: All Organs

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-5:40pm

Location: Hynes Ballroom B

*Purpose: Expansion of the donor pool remains a major unmet need for solid organ transplants (SOT). Early data suggests that at least some severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID) nucleic acid test positive (NAT+) organs could be transplanted safely although there is substantial controversy about this topic.

*Methods: A retrospective analysis of the national United States Organ Procurement and Transplantation Network database was performed, demonstrating initial experience with COVID NAT+ deceased donor organs with a focus on kidney transplants, from August 8, 2020, to Sep 29, 2021.

*Results: During this time period, 17,143 COVID NAT negative (NAT-) deceased donors and 150 COVID NAT+ deceased donors were assessed for organ donation (Figure 1) (Table 1). When compared to COVID NAT- donors, there was a higher (p<0.001 for all) non-recovery rate for COVID NAT+ hearts (35% vs 87%), lungs (71% vs 99%), livers (24% vs 53%), and pancreas (89% vs 98 %). Of a total of 385 recovered organs from 150 COVID NAT+ donors, 276 (72%) organs were transplanted into 262 recipients. Majority of donors had a COVID NAT+ ≤7 days prior to procurement (94; 62.7%). While only a minority of pancreases, hearts, lungs, and livers were procured, almost all were transplanted post-procurement. In contrast, there was a high discard rate for kidneys post-procurement (102/295; 34.6%) with the most common reason (~70%) for discards being ‘exhaustion of the wait list’. Presumably superior quality COVID NAT+ kidneys were discarded compared with COVID NAT- kidneys (mean KDPI: 67% vs 76%; p=0.04). Limited outcome data was available with a median post-transplant follow-up of 75 days (range: 23-243 days). Three kidney allograft losses (2 due to allograft thrombosis) and five deaths (2 kidneys, 3 livers) were reported, of which, one was due to respiratory failure and one due to sepsis.

*Conclusions: These data provide early reassuring evidence on the utilization of non-lung COVID NAT+ organs. However, a substantially lower procurement rate for non-kidney transplantable organs and a high discard rate for kidneys were noted.

COVID NAT Positive Deceased Donor Characteristics
Positive COVID NAT Result- n (%) 150 (100)
COVID NAT test site- n (%)
Lower respiratory
Upper respiratory
Rectal
13 (8)
136 (91)
1 (1)
Age (years) – mean (SD)
Sex (male) – n (%)
BMI (kg/m2)-mean (SD)
Caucasian Race- n (%)
Kidney Donor Profile Index – mean (SD, %)
Terminal Creatinine (mg/dl)-median (IQR)
43 (14)
98 (65)
32 (9.5)
91 (61)
48 (27)
0.89 (0.53, 1.5)
Pulmonary Infection-n (%)
Chest X-ray-n(%)
Normal
Abnormalleft
Abnormal right
Abnormal both
74 (49)
13 (10)
9 (7)
9 (7)
96 (76)
Cause of death -n (%)
Anoxia
Stroke
Other
48 (32)
33 (22)
69 (46)
Right kidney reason for discard, n (%)
Donor’s medical history
Biopsy finding
Poor organ function
No recipient located list exhausted
Unknown
1 (2.5)
3 (7.5)
2 (5)
27 (67.5)
7 (17.5)
Left kidney reason for discard, n (%)
Biopsy finding
Poor organ function
No recipient locatedlist exhausted
Unknown
3 (8)
1 (3)
27 (73)
6 (16)
Double kidneys reason for discard, n (%)
No recipient located list exhausted
Unknown
4 (80)
1 (20)
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Azhar A, Moinuddin I, Gungor AB, Morales MK, Molnar MZ, Tanriover B, Gupta G. Utilization and Discard of Organs from Covid -19 Infected Donors: A Us National Registry Analysis [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/utilization-and-discard-of-organs-from-covid-19-infected-donors-a-us-national-registry-analysis/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences